Similar articles for PMID: 16355673

Year	Number of Results
1978	1
1985	1
1987	1
1988	2
1989	1
1990	1
1991	1
1992	3
1994	2
1995	3
1996	1
1997	5
1998	8
1999	4
2000	1
2001	1
2002	4
2003	5
2004	6
2005	8
2006	5
2007	5
2008	7
2009	1
2010	5
2011	5
2012	4
2013	7
2014	8
2015	3
2016	8
2017	4
2018	4
2019	1
2020	4
2021	6
2022	3
2023	3
2024	0

1

A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism.

Barker EN, Campbell S, Tebb AJ, Neiger R, Herrtage ME, Reid SW, Ramsey IK. Barker EN, et al. J Vet Intern Med. 2005 Nov-Dec;19(6):810-5. doi: 10.1892/0891-6640(2005)19[810:acotst]2.0.co;2. J Vet Intern Med. 2005. PMID: 16355673 Free article.

2

Comparison of non-selective adrenocorticolysis with mitotane or trilostane for the treatment of dogs with pituitary-dependent hyperadrenocorticism.

Clemente M, De Andrés PJ, Arenas C, Melián C, Morales M, Pérez-Alenza MD. Clemente M, et al. Vet Rec. 2007 Dec 15;161(24):805-9. Vet Rec. 2007. PMID: 18083978

3

A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane.

Helm JR, McLauchlan G, Boden LA, Frowde PE, Collings AJ, Tebb AJ, Elwood CM, Herrtage ME, Parkin TD, Ramsey IK. Helm JR, et al. J Vet Intern Med. 2011 Mar-Apr;25(2):251-60. doi: 10.1111/j.1939-1676.2011.0696.x. Epub 2011 Feb 25. J Vet Intern Med. 2011. PMID: 21352377 Free article.

4

Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.

Reine NJ. Reine NJ. Clin Tech Small Anim Pract. 2007 Feb;22(1):18-25. doi: 10.1053/j.ctsap.2007.02.003. Clin Tech Small Anim Pract. 2007. PMID: 17542193 Review.

5

Long-term survival of dogs with adrenal-dependent hyperadrenocorticism: a comparison between mitotane and twice daily trilostane treatment.

Arenas C, Melián C, Pérez-Alenza MD. Arenas C, et al. J Vet Intern Med. 2014 Mar-Apr;28(2):473-80. doi: 10.1111/jvim.12303. Epub 2014 Feb 3. J Vet Intern Med. 2014. PMID: 24495125 Free PMC article.

6

Old or new? A comparison of mitotane and trilostane for the management of hyperadrenocorticism.

Griffies JD. Griffies JD. Compend Contin Educ Vet. 2013 May;35(5):E3. Compend Contin Educ Vet. 2013. PMID: 23677783

7

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog.

Park SM, Kim KB, Song WJ, Youn HY. Park SM, et al. Vet Med Sci. 2021 Jul;7(4):1150-1153. doi: 10.1002/vms3.482. Epub 2021 Mar 23. Vet Med Sci. 2021. PMID: 33755348 Free PMC article.

8

Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.

Aldridge C, Behrend EN, Kemppainen RJ, Lee-Fowler TM, Martin LG, Ward CR, Bruyette D, Pannu J, Gaillard P, Lee HP. Aldridge C, et al. J Vet Intern Med. 2016 Sep;30(5):1637-1641. doi: 10.1111/jvim.14528. Epub 2016 Jul 18. J Vet Intern Med. 2016. PMID: 27425787 Free PMC article. Clinical Trial.

9

Comparison of Survival Times for Dogs with Pituitary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated.

Nagata N, Kojima K, Yuki M. Nagata N, et al. J Vet Intern Med. 2017 Jan;31(1):22-28. doi: 10.1111/jvim.14617. Epub 2016 Dec 1. J Vet Intern Med. 2017. PMID: 27906457 Free PMC article.

10

Hyperadrenocorticism: treating dogs.

Brown CG, Graves TK. Brown CG, et al. Compend Contin Educ Vet. 2007 Mar;29(3):132-4, 136, 138 passim; quiz 144-5. Compend Contin Educ Vet. 2007. PMID: 17726933 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

130 results

Results by year